Compare KALV & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KALV | NFGC |
|---|---|---|
| Founded | N/A | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 551.2M | 588.1M |
| IPO Year | N/A | N/A |
| Metric | KALV | NFGC |
|---|---|---|
| Price | $16.32 | $2.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $26.43 | $5.00 |
| AVG Volume (30 Days) | ★ 1.8M | 1.7M |
| Earning Date | 11-10-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,426,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $204.16 | $1,903.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.30 | $0.93 |
| 52 Week High | $17.28 | $3.28 |
| Indicator | KALV | NFGC |
|---|---|---|
| Relative Strength Index (RSI) | 67.20 | 63.83 |
| Support Level | $13.28 | $2.72 |
| Resistance Level | $16.80 | $3.28 |
| Average True Range (ATR) | 1.09 | 0.18 |
| MACD | 0.28 | 0.06 |
| Stochastic Oscillator | 79.32 | 65.46 |
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Company's exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).